Article
Inorganic Chemistry, Vol. 49, No. 18, 2010 8617
THF was evaporated, and the aqueous phase was extracted
with 3 ꢁ 50 mL of CH2Cl2. The combined extracts were dried
over Na2SO4, filtered, and evaporated to dryness to yield 1.00 g
(98%) of 13.
1H NMR (CDCl3): δ 8.66 (t, 2H, 4J = 1.4 Hz), 8.61 (d, 2H,
3J=8.4 Hz), 8.32 (d, 4H, 3J=8.5 Hz), 8.26 (t, 1H, 3J=8.4 Hz),
8.20 (d, 4H, 3J=8.4 Hz), 8.02 (d, 4H, 4J=1.5 Hz), 7.89 (d, 2H,
4J=1.8 Hz), 7.74 (d, 8H, 3J=8.5 Hz), 7.69 (d, 8H, 3J=8.5 Hz),
7.62 (d, 2H, 3J=9.1 Hz), 7.52 (d, 4H, 4J=2.0 Hz), 7.49 (dd, 4H,
3J=8.3 Hz, 4J=2.0 Hz), 7.38 (dd, 2H, 3J=9.0 Hz, 4J=1.9 Hz),
7.29 (d, 4H, 3J=8.4 Hz), 4.85 (q, 4H, 3J=7.0 Hz), 4.38 (t, 4H,
3J=6.7 Hz), 4.15 (t, 4H, 3J=6.4 Hz), 2.34 (s, 12H), 1.77-1.92
(m, 8H), 1.48(t, 6H, 3J=7.2 Hz), 1.30-1.58(m, 24H). ESI-MS:m/z
1H NMR (CDCl3): δ 8.65 (t, 1H, 4J = 1.4 Hz), 8.15 (d, 2H,
3J=8.4 Hz), 8.11 (d, 2H, 3J=8.4 Hz), 8.01 (d, 2H, 4J=1.4 Hz),
7.73 (d, 4H, 3J=8.3 Hz), 7.68 (d, 4H, 3J=8.4 Hz), 7.51 (d, 2H,
4J=2.2 Hz), 7.49 (dd, 2H, 3J=8.3 Hz, 4J=2.2 Hz), 7.27 (d, 2H,
3J=8.2 Hz), 4.35 (t, 2H, 3J=6.7 Hz), 4.13 (t, 2H, 3J=6.3 Hz),
2.33 (s, 6H), 1.74-1.90 (m, 4H), 1.30-1.56 (m, 12H). ESI-MS: m/z
2101.2 ([M þ H]þ). Elem anal. Calcd for C131H113N9O18 1.07H2O:
3
867.7 ([M - H]-). Elem anal. Calcd for C54H48N2O9 1.97H2O: C,
C, 74.19; H, 5.47; N, 5.94. Found: C, 74.21; H, 5.49; N, 5.75.
Preparation of Ligand L9. A solution of 14 (0.30 g, 0.34 mmol),
2,6-bis(1-ethyl-5-hydroxybenzimidazol-2-yl)pyridine (0.069 g, 0.17
3
71.72; H, 5.79; N, 3.10. Found: C, 71.73; H, 5.91; N, 2.97.
Preparation of Compound 14. To a solution of 10 (0.32 g, 0.37
mmol) in 25 mL of THF and 25 mL of H2O was added NaClO2
(0.18 g, 2.0 mmol) and H2NSO3H (0.19 g, 2.0 mmol). After
stirring for 2 h at room temperature, THF was evaporated and
the aqueous solution extracted with CH2Cl2 (3 ꢁ 25 mL). Eva-
poration yielded 0.30 g (92%) of 14.
mmol), EDCI HCl (0.19 g, 1.0 mmol), and DMAP (0.12 g, 1.0
3
mmol) in 50 mL of dry CH2Cl2 was refluxed under an atmosphere
of N2 for 14 h. After washing with a saturated aqueous NaCl
solution (3 ꢁ 50 mL), the organic phase was dried over Na2SO4,
filtered, and evaporated to dryness. Purification by column chro-
matography (silica; CH2Cl2/CH3OH=100/0 f 98.5/1.5) gave 0.07
g (20%) of L9.
1H NMR (CDCl3): δ 8.61 (t, 1H, 4J=1.5 Hz), 8.11-8.17 (m,
4H), 7.98 (d, 2H, 4J = 1.5 Hz), 7.73 (d, 4H, 3J = 8.2 Hz), 7.46
(d, 4H, 3J=8.3 Hz), 7.27 (d, 2H, 3J=8.4 Hz), 7.19 (d, 2H, 4J=
2.2 Hz), 7.15 (dd, 2H, 3J=8.4 Hz, 4J=2.3 Hz), 4.35 (t, 2H, 3J=
1H NMR (CDCl3): δ 8.61 (t, 2H, 4J = 1.6 Hz), 8.45 (d, 2H,
3J=8.3 Hz), 8.32 (d, 4H, 3J=8.6 Hz), 8.20 (d, 4H, 3J=8.5 Hz),
8.14 (t, 1H, 3J=8.1 Hz), 7.98 (d, 4H, 4J=1.5 Hz), 7.76 (d, 2H,
4J=1.6 Hz), 7.72 (d, 8H, 3J=8.4 Hz), 7.55 (d, 2H, 3J=8.8 Hz),
7.45 (d, 8H, 3J=8.5 Hz), 7.29 (dd, 2H, 3J=8.9 Hz, 4J=1.9 Hz),
7.27 (d, 4H, 3J=8.5 Hz), 7.19 (d, 4H, 4J=2.4 Hz), 7.15 (dd, 4H,
3J=8.4 Hz, 4J=2.5 Hz), 4.83 (q, 4H, 3J=6.9 Hz), 4.38 (t, 4H,
3J=6.9 Hz), 4.13 (t, 4H, 3J=6.6 Hz), 2.29 (s, 12H), 1.75-1.92
(m, 8H), 1.42-1.57 (m, 8H), 1.43 (t, 6H, 3J=7.1 Hz), 1.31-1.42
(m, 8H). ESI-MS: m/z 2101.1 ([M þ H]þ). Elem anal. Calcd for
3
6.7 Hz), 4.12 (t, 2H, J = 6.7 Hz), 2.29 (s, 6H), 1.75-1.89 (m,
4H), 1.42-1.54 (m, 4H), 1.30-1.42 (m, 8H). ESI-MS: m/z 867.7
([M - H]-). Elem anal. Calcd for C54H48N2O9 2.58H2O: C,
3
70.84; H, 5.85; N, 3.06. Found: C, 70.86; H, 6.02; N, 2.95.
Preparation of Compound 15. A solution of 11 (0.83 g, 0.94
mmol), NaClO2 (0.45 g, 5.0 mmol), and H2NSO3H (0.49 g, 5.0
mmol) in 50 mL of THF and 50 mL of H2O was stirred for 4 h.
THF was evaporated, and the aqueous phase was extracted with
3 ꢁ 150 mL of CH2Cl2. The combined organic extracts were
dried over Na2SO4, filtered, and evaporated to dryness. Yield:
0.79 g (93%) of 15.
C
131H113N9O18 3.73H2O: C, 72.56; H, 5.60; N, 5.81. Found: C,
3
72.57; H, 5.58; N, 5.62.
Preparation of Ligand L10. A solution of 2,6-bis(1-ethyl-5-
hydroxybenzimidazol-2-yl)pyridine (0.176 g, 0.44 mmol) and 15
(0.79 g, 0.88 mmol) in 50 mL of freshly distilled CH2Cl2 was
cooled in an ice bath. After the addition of DCC (0.41 g, 1.99
mmol), DPTS (0.26 g, 0.88 mmol), and a spatula tip of 4-PPy,
the ice bath was allowed to melt and the reaction mixture was
stirred at room temperature for 16 h. The solution was filtered
and evaporated to dryness. The crude product was cleaned by
column chromatography (silica; CH2Cl2/CH3OH=100/0 f 99/1)
to yield 0.18 g (19%) of L10.
1H NMR (CDCl3): δ 8.61 (t, 1H, 4J = 1.5 Hz), 8.16 (d, 2H,
3J=8.3 Hz), 8.13 (d, 2H, 3J=8.4 Hz), 7.98 (d, 2H, 4J=1.4 Hz),
7.59 (d, 2H, 4J=1.5 Hz), 7.55 (dd, 2H, 3J=7.7 Hz, 4J=1.4 Hz),
7.25 (d, 2H, 3J=7.8 Hz), 7.19 (m, 2H), 7.11-7.17 (m, 4H), 4.35
(t, 2H, 3J=6.9 Hz), 4.12 (t, 2H, 3J=6.5 Hz), 2.13 (s, 6H), 2.07 (s,
6H), 1.77-1.84 (m, 4H), 1.29-1.53 (m, 12H). ESI-MS: m/z
895.1 ([M - H]-). Elem anal. Calcd for C56H52N2O9 1.07H2O:
3
C, 73.40; H, 5.96; N, 3.06. Found: C, 73.43; H, 6.27; N, 2.84.
Preparation of Ligand L7. A solution of 2,6-bis(1-ethyl-5-
hydroxybenzimidazol-2-yl)pyridine (0.20 g, 0.50 mmol), 12
1H NMR (CDCl3): δ 8.62 (t, 2H, 4J = 1.5 Hz), 8.36 (d, 2H,
3J=7.8 Hz), 8.33 (d, 4H, 3J=8.6 Hz), 8.20 (d, 4H, 3J=8.5 Hz),
8.08 (t, 1H, 3J=7.8 Hz), 7.98 (d, 4H, 4J=1.4 Hz), 7.70 (d, 2H,
4J=2.1 Hz), 7.59 (d, 4H, 4J=1.4 Hz), 7.54 (dd, 4H, 3J=7.6 Hz,
4J=1.4 Hz), 7.27 (dd, 2H, 3J=8.9 Hz, 4J=1.9 Hz), 7.25 (d, 4H,
3J=7.8 Hz), 7.19 (m, 4H), 7.11-7.17 (m, 8H), 4.82 (q, 4H, 3J=
7.3 Hz), 4.38 (t, 4H, 3J=6.7 Hz), 4.13 (t, 4H, 3J=6.5 Hz), 2.13
(s, 12H), 2.07 (s, 12H), 1.77-1.92 (m, 8H), 1.41 (t, 6H, 3J=7.2
Hz), 1.31-1.57 (m, 24H). ESI-MS: m/z 2157.0 ([M þ H]þ). Elem
(0.84 g, 1.0 mmol), EDCI HCl (0.60 g, 3.13 mmol), and DMAP
3
(0.38 g, 3.11 mmol) in 50 mL of freshly distilled CH2Cl2 was
refluxed under N2 for 16 h. After washing with 3 ꢁ 50 mL of a
saturated aqueous NaCl solution, the organic phase was dried
over Na2SO4, filtered, and evaporated. Purification by column
chromatography (silica; CH2Cl2/CH3OH = 100/0 f 98.5/1.5)
gave 0.45 g (44%) of L7.
1H NMR (CDCl3): δ 8.62 (t, 2H, 4J = 1.4 Hz), 8.42 (d, 2H,
3J=8.5 Hz), 8.32 (d, 4H, 3J=8.5 Hz), 8.19 (d, 4H, 3J=8.5 Hz),
8.12 (d, 2H, 3J=8.5 Hz), 7.99 (d, 4H, 4J=1.5 Hz), 7.75 (d, 8H,
3J=8.3 Hz), 7.75 (d, 2H, 3J=8.3 Hz), 7.69 (d, 8H, 3J=8.5 Hz),
7.67 (d, 8H, 3J=8.8 Hz), 7.54 (d, 2H, 3J=8.8 Hz), 7.37 (d, 8H,
3J=8.7 Hz), 7.27 (d, 2H, 3J=8.8 Hz), 4.38 (t, 4H, 3J=6.6 Hz),
anal. Calcd for C135H121N9O18 2.05H2O: C, 73.89; H, 5.75; N,
3
5.74. Found: C, 73.92; H, 6.01; N, 5.57.
Preparation of Compound 29. To a suspension of 5-(tert-
butyldimethylsiloxy)isophthalic acid (0.70 g, 2.35 mmol) in 50 mL
of freshly distilled CH2Cl2 stirred in an ice bath was added first a
solution of DCC (3.00 g, 14.5 mmol), DPTS (0.30 g, 1.02 mmol),
and a spatula tip of 4-PPy in 25 mL of CH2Cl2 and then a
solution of 17 (2.28 g, 4.70 mmol) in 25 mL of CH2Cl2. After
stirring for 30 min, the ice bath was removed and the solution
was stirred for 17 h. After filtration, the solution was evaporated
to dryness. The crude product was purified by column chroma-
tography (silica; CH2Cl2/CH3OH = 100/0 f 99.5/0.5) to yield
2.21 g (79%) of 29.
3
4.14 (t, 4H, J = 6.5 Hz), 1.77-1.92 (m, 8H), 1.32-1.55 (m,
24H). ESI-MS: m/z 2044.9 ([M þ H]þ). Elem anal. Calcd for
C127H105N9O18 2.72H2O: C, 72.84; H, 5.32; N, 6.02. Found: C,
72.84; H, 5.18; N, 5.83.
3
Preparation of Ligand L8. A solution of 13 (0.52 g, 0.60
mmol), 2,6-bis(1-ethyl-5-hydroxybenzimidazol-2-yl)pyridine
(0.12 g, 0.30 mmol), EDCI HCl (0.38 g, 2.0 mmol), and DMAP
3
(0.24 g, 2 mmol) in 50 mL of dry CH2Cl2 was refluxed under N2
for 18 h. The solution was washed with 3 ꢁ 50 mL of a saturated
aqueous NaCl solution, and the organic phase was dried over
Na2SO4, filtered, and evaporated. The crude product was purified
by column chromatography (silica; CH2Cl2/CH3OH=100/0 f
98.5/1.5) to yield 0.19 g (30%) of L8.
1H NMR (CDCl3): δ 8.28 (t, 1H, 4J = 1.5 Hz), 8.17 (d, 4H,
3J=9.0 Hz), 7.72 (d, 4H, 3J=8.7 Hz), 7.67 (d, 4H, 3J=8.9 Hz),
7.67 (d, 2H, 4J=1.5 Hz), 7.48 (d, 2H, 4J=1.8 Hz), 7.46 (dd, 2H,
3J=8.2 Hz, 4J=2.3 Hz), 7.24 (d, 2H, 3J=8.2 Hz), 6.99 (d, 4H,
3J=8.9 Hz), 4.33 (t, 4H, 3J=6.8 Hz), 4.05 (t, 4H, 3J=6.6 Hz),